Kewaunee Scientific (KEQU) Liabilities and Shareholders Equity (2011 - 2026)

Kewaunee Scientific's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $178.3 million for Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 8.4% year-over-year to $178.3 million in Q2 2026; TTM through Apr 2026 was $736.8 million, a 13.31% increase from a year earlier, with the FY2026 full-year figure at $178.3 million, down 8.4% from the prior year.
• Liabilities and Shareholders Equity advanced to $178.3 million in Q2 2026 per KEQU's latest filing, from $176.0 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $194.7 million in Q2 2025 and bottomed at $95.7 million in Q1 2022.
• The 5-year median for Liabilities and Shareholders Equity is $129.2 million (2024), against an average of $144.1 million.
• Across the five-year window, Liabilities and Shareholders Equity jumped 49.75% in 2025 and decreased 8.4% in 2026, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $119.1 million in 2022, then gained by 2.17% to $121.7 million in 2023, then gained by 10.49% to $134.5 million in 2024, then jumped by 40.6% to $189.1 million in 2025, then slipped by 5.69% to $178.3 million in 2026.
• Per Business Quant, the three latest KEQU Liabilities and Shareholders Equity figures stand at $178.3 million (Q2 2026), $176.0 million (Q1 2026), and $189.1 million (Q4 2025).